We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antimicrobial ‘Superfoam’ Could Reduce Infections from Implanted Medical Devices

By HospiMedica International staff writers
Posted on 01 May 2023

Each year, over 500,000 patients suffer from health care-related infections caused by medical implants. More...

Existing medical devices are susceptible to contamination, as proteins, which are the first to adhere to a surface, act like glue, enabling blood or bacteria to attach. Preventing protein adsorption is therefore crucial. Now, a new, versatile foam material could significantly decrease infections related to implanted medical devices. This porous, three-dimensional foam is water-repellent, which means it resists blood, microbes, and proteins. Its versatility, functionality, and relatively low production costs could make it an invaluable asset for future clinicians.

Scientists at University of Georgia (Athens, GA, USA) have developed a coarse foam material with two added components: hydrophobic (water-repellent) electrically conductive graphene nanoplatelets and hydrophobic bactericidal copper microparticles. These additions not only repel water but also create a coarse surface that enhances oil adsorption capacity. Moreover, the copper, a known bacterial toxin, imparts antimicrobial properties to the surface. The material's effectiveness was confirmed through testing, which revealed a 99.9% bacterial reduction using E. coli as the test bacterium when compared to a simple polymer. The researchers will now aim to apply this surface to medical devices and demonstrate its efficacy before progressing to non-human animal trials and eventually human testing.

 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.